This analysis looked at six studies involving patients with primary hypertension. Researchers compared taking amlodipine with an angiotensin receptor blocker to taking amlodipine by itself. The goal was to see if the combination helped control blood pressure better and if it caused more side effects. The studies followed patients for at least eight weeks.
The results showed that the combination therapy was linked to better blood pressure control. Specifically, the odds of achieving good blood pressure control were 2.25 times higher with the combination compared to amlodipine alone. This difference was statistically significant, with a confidence interval ranging from 1.78 to 2.83.
No safety concerns were reported in the included studies. There were no reports of adverse events, serious side effects, or reasons for stopping the medication. Because this is a meta-analysis of existing studies, the findings suggest a potential benefit, but readers should remember that this is a review of data rather than a single new trial. The evidence supports considering this combination for blood pressure management.